title: Primary duodenal follicular lymphoma successfully treated with rituximab.
abstract: Non-Hodgkin's lymphoma (NHL) of the gastrointestinal (GI) tract is the most common extranodal lymphoma, accounting for approximately 40% of all extranodal NHLs. Initial treatment of duodenal lymphoma includes surgery, chemotherapy and radiotherapy, alone or in combination. Here, we present a case of stage I primary duodenal follicular lymphoma (FL) showing a complete response after rituximab therapy. Rituximab alone can be an effective alternative treatment for duodenal FL.
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain. dagubuj@gobiernodecanarias.org
authors.forename: D
authors.initials: D
authors.lastname: Aguiar-Bujanda
authors.forename: I
authors.initials: I
authors.lastname: Quiñones-Morales
authors.forename: R
authors.initials: R
authors.lastname: Camacho-Galán
authors.forename: I
authors.initials: I
authors.lastname: Llorca-Martínez
authors.forename: J C
authors.initials: JC
authors.lastname: Rivero-Vera
authors.forename: U
authors.initials: U
authors.lastname: Bohn-Sarmiento
authors.forename: J
authors.initials: J
authors.lastname: Aguiar-Morales
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004379:Duodenal Neoplasms / Q000188:drug therapy*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab